David R. Rahn & Associates Inc. Regeneron Pharmaceuticals, Inc. Transaction History

David R. Rahn & Associates Inc.

  • $294 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 12, 2019
SELL
$372.08 - $439.57 $1.21 Million - $1.43 Million
-3,245 Closed
0 $0
Q4 2018

Jan 16, 2019
SELL
$335.82 - $403.04 $424,476 - $509,442
-1,264 Reduced 28.03%
3,245 $1.21 Million
Q3 2018

Oct 18, 2018
BUY
$351.14 - $408.51 $1.58 Million - $1.84 Million
4,509 New
4,509 $1.82 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track David R. Rahn & Associates Inc. Portfolio

Follow David R. Rahn & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of David R. Rahn & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on David R. Rahn & Associates Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email